Skip to main content
Signal8

Schelman William

SEC insider (Form 3/4/5 filer). CIK 0002132269. Chief Medical Officer at Bicara Therapeutics Inc. (BCAX). 1 reported Form 4/5 transaction since Sep 2024; latest on May 8, 2026. Located in BOSTON, MA.

Companies Schelman William has filed insider reports for

  • Bicara Therapeutics Inc. (BCAX): Officer, Chief Medical Officer
Schelman William profile photo

Schelman William

CIK: 0002132269

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)1 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Bicara Therapeutics Inc. logo
BCAX

Bicara Therapeutics Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (1 total)

  • Bicara Therapeutics Inc. logo
    BCAX

    Bicara Therapeutics Inc.

    May 8, 2026
    Award

    Stock Option (Right to Buy)

    Direct
    85K shares-

1-1 of 1